J&J Submits McNeil Plant Reforms To FDA, Announces Layoffs
This article was originally published in The Tan Sheet
Executive Summary
The firm submits a remediation plan for correcting quality control issues and investing in long-term improvements at its Fort Washington, Pa., plant. While the facility remains shuttered, about 75% of its positions are being eliminated and OTC production shifted elsewhere.